1983
DOI: 10.1093/nar/11.18.6419
|View full text |Cite
|
Sign up to set email alerts
|

Chemical synthesis of a human interferon-α2, gene and its expression inEscherichia coli

Abstract: A 511-base pair DNA fragment encoding human interferon-alpha 2 has been chemically synthesised and expressed from a lac UV5 and a synthetic trp promoter in Escherichia coli. The synthesis involved preparation of 68 oligodeoxyribonucleotides and their enzymic ligation. The product expressed from the trp promoter system had high antiviral activity and displayed biological effects similar to those of Namalwa interferon on natural killer cell activity and in a Daudi cell growth inhibition assay. E.coli minicells c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
10
0

Year Published

1984
1984
1999
1999

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(10 citation statements)
references
References 38 publications
0
10
0
Order By: Relevance
“…Synthesis of the Gene. The approach adopted for preparing the gene consisted of synthesizing oligodeoxynucleotide segments representing the desired sequence for the two DNA strands and ligating them to form the complete gene (18)(19)(20)(21)(22)(23). The designed fragment carrying the CSa gene was divided into three subfragments ("thirds") extending from nucleotide residues 1 to 60, 61 to 157, and 158 to 253.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Synthesis of the Gene. The approach adopted for preparing the gene consisted of synthesizing oligodeoxynucleotide segments representing the desired sequence for the two DNA strands and ligating them to form the complete gene (18)(19)(20)(21)(22)(23). The designed fragment carrying the CSa gene was divided into three subfragments ("thirds") extending from nucleotide residues 1 to 60, 61 to 157, and 158 to 253.…”
Section: Resultsmentioning
confidence: 99%
“…The ability to test additional variant or mutant forms of C5a would provide insight concerning which residues are important for its biological activity. Recent advances in recombinant DNA technology now make it feasible both to approach the problem of inadequate supply of a scarce protein and to generate a system for mutagenesis by cloning the gene coding for the protein and having it expressed in bacteria (18)(19)(20)(21)(22)(23)(24). Chemical synthesis is a preferred method to obtain a C5a gene, since C5a is a cleavage product of a larger protein.…”
mentioning
confidence: 99%
“…Enzymatic ligation of the 78 chemically synthesized oligonucleotides was carried out by joining [5][6][7][8][9][10] pieces in the first step. The subfragments thus obtained were further ligated to yield 415-bp (A+B segment: amino-terminus portion) and 176-bp (C segment: carboxylterminus portion) polynucleotides.…”
Section: Resultsmentioning
confidence: 99%
“…Deoxyoligonucleotides with a chain length of [7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] bases were synthesized by the phosphotriester solid-phase method, using 1% cross-linked polystyrene (15) as the support. Altogether 78 chains were prepared by addition of dinucleotide blocks to the nucleosides linked through a 3'-succinyl group to the resin.…”
Section: Methodsmentioning
confidence: 99%
“…The therapeutic efficacy of human IFNs has been established in the treatment of certain human cancers and viral diseases (1). Recombinant human IFN-␣ (rh-IFN-␣) is used for the treatment of hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic hepatitis B and C (2,3) and has been obtained by the expression of the IFN-␣ gene in Escherichia coli (4) or yeast (5).…”
mentioning
confidence: 99%